Literature DB >> 12706495

Plasma 3-nitrotyrosine and outcome in neonates with severe bronchopulmonary dysplasia after inhaled nitric oxide.

Scott A Lorch1, Beverly A Banks, Jason Christie, Jeffrey D Merrill, John Althaus, Keri Schmidt, Philip L Ballard, Harry Ischiropoulos, Roberta A Ballard.   

Abstract

Plasma protein levels of 3-nitrotyrosine and 3-chlorotyrosine were measured by LC-MS/MS at 0 and 72 h after the initiation of inhaled nitric oxide (INO) at 20 ppm in 22 prematurely born infants with clinically documented bronchopulmonary dysplasia. Infants were classified at the time of hospital discharge as either "off mechanical ventilation," "on mechanical ventilation," or "expired/organ failure." These outcomes were tested for association with changes in plasma levels of 3-nitrotyrosine and 3-chlorotyrosine and selected clinical risk factors. Infants whose 3-nitrotyrosine levels decreased over the 72 h period were more likely to wean off of mechanical ventilation (p =.03). There was no significant association between changes in 3-chlorotyrosne levels and outcome. After controlling for other variables, an odds ratio of 8.3 (95% CI: 1.3-54.4) for improved outcomes was observed if the 3-nitrotyrosine levels decreased. These data suggest that nitrative and oxidative stress may be related to the severity of lung disease and, consequentially, the overall outcome in this select group of infants with severe bronchopulmonary dysplasia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706495     DOI: 10.1016/s0891-5849(03)00063-7

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  5 in total

1.  Inhaled nitric oxide prevents 3-nitrotyrosine formation in the lungs of neonatal mice exposed to >95% oxygen.

Authors:  Michael R Stenger; Melissa J Rose; Mandar S Joshi; Lynette K Rogers; Louis G Chicoine; John Anthony Bauer; Leif D Nelin
Journal:  Lung       Date:  2010-03-17       Impact factor: 2.584

2.  Opposing regulation of human alveolar type II cell differentiation by nitric oxide and hyperoxia.

Authors:  Lindsay C Johnston; Linda W Gonzales; Richard T Lightfoot; Susan H Guttentag; Harry Ischiropoulos
Journal:  Pediatr Res       Date:  2010-05       Impact factor: 3.756

3.  Inflammatory Mediators in Tracheal Aspirates of Preterm Infants Participating in a Randomized Trial of Inhaled Nitric Oxide.

Authors:  Mandy Laube; Elena Amann; Ulrike Uhlig; Yang Yang; Hans W Fuchs; Michael Zemlin; Jean-Christophe Mercier; Rolf F Maier; Helmut D Hummler; Stefan Uhlig; Ulrich H Thome
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

4.  Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites.

Authors:  M A Posencheg; A J Gow; W E Truog; R A Ballard; A Cnaan; S G Golombek; P L Ballard
Journal:  J Perinatol       Date:  2009-10-08       Impact factor: 2.521

Review 5.  Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity.

Authors:  Gloria S Pryhuber
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.